Prime Medicine, Inc. (PRME)
3.255
-0.14
(-3.98%)
USD |
NASDAQ |
Aug 24, 16:00
3.26
0.00 (0.00%)
After-Hours: 20:00
Prime Medicine Shareholders Equity (Quarterly) : 39.81M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 39.81M |
| March 31, 2026 | 76.70M |
| December 31, 2025 | 120.87M |
| September 30, 2025 | 161.82M |
| June 30, 2025 | 60.86M |
| March 31, 2025 | 106.92M |
| December 31, 2024 | 153.15M |
| September 30, 2024 | 189.50M |
| June 30, 2024 | 196.59M |
| March 31, 2024 | 243.77M |
| December 31, 2023 | 133.07M |
| September 30, 2023 | 193.96M |
| Date | Value |
|---|---|
| June 30, 2023 | 240.10M |
| March 31, 2023 | 278.80M |
| December 31, 2022 | 316.27M |
| September 30, 2022 | 172.70M |
| June 30, 2022 | 200.74M |
| March 31, 2022 | 228.86M |
| December 31, 2021 | 239.56M |
| September 30, 2021 | 301.38M |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | 33.47M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Beam Therapeutics, Inc. | 1.067B |
| Twist Bioscience Corp. | 445.74M |
| Sana Biotechnology, Inc. | 154.57M |
| Generate Biomedicines, Inc. | 456.04M |
| Intellia Therapeutics, Inc. | 727.71M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 249.04M |
| Total Liabilities (Quarterly) | 209.23M |
| Debt to Equity Ratio | 2.825 |
| Current Ratio | 3.054 |
| Net Debt Paydown Yield | 0.26% |